Asia Pacific Fish Vaccines Market Forecast to 2030
Asia Pacific Fish Vaccines Market Forecast to 2030 – Regional Analysis – by Vaccine Type (Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Recombinant Vector Vaccine, and Others), Application (Bacterial Infection, Viral Infection, and Parasitic), Route of Administration (Injection Vaccine, Immersion Vaccine, and Oral Vaccine), and Species (Salmon, Trout, Tilapia, and Others)
$2,840 – $4,440
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Development of Novel Fish Vaccine Fuels the Asia Pacific Fish Vaccine Market
Emergence of disease outbreak caused by parasites, viruses, and bacteria have slowed down the evolution of the global aquaculture industry for several decades. Aside from being harmful to human health, emerging diseases have a significant impact on aquatic animals. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Newer avenues in the basic and applied research fields of aquatic vaccines have been opened up by scientific and technological advancements. An effort has been made to create novel aquatic vaccines with higher quality and efficiency using new technologies, approaches, and strategies.
Using the available bioinformatics tools and current knowledge of immunoproteomics and genomics, researchers can identify potential targeted epitopes that immune cells can recognize. Further, as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. This is likely to boost investments in developing new vaccines. In 2021, the Central Institute of Brackishwater Aquaculture (ICAR) launched a recombinant vaccine against viral nervous necrosis (VNN) in India.
Thus, the development of an effective mucosal vaccine with strengthening the administration process is expected to accelerate the novel vaccine development, which would boost the aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. Hence, development of novel fish vaccines is likely creating significant opportunity for market growth.
Asia Pacific Fish Vaccines Market Overview
The Asia Pacific fish vaccines market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in these countries is attributed to the rising aquaculture sector in the region and favorable government initiatives. Moreover, expansion and product launch strategies implemented by market players are expected to contribute to the growth of the fish vaccines market in the region. Commercial aquaculture production in Japan has developed dramatically since the end of the 2nd World War and occupies an important place in the fisheries sector. More than 60 species are included in the aquaculture section of the annual fisheries statistics. Of these, the main species are Nori, yesso scallop, oyster, Japanese amberjack, red seabream, and sea mustard. However, domestic demand for seafood products will decline in the next decade, and the production of aquaculture will decline if it remains dependent on domestic demand. This decline in demand in Japan is because Japan’s population is dropping, and their diets are shifting toward meat.
Asia Pacific Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Fish Vaccines Market Segmentation
The Asia Pacific fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.
Based on vaccine type, the Asia Pacific fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.
Based on application, the Asia Pacific fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.
Based on route of administration, the Asia Pacific fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.
Based on species, the Asia Pacific fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.
Based on country, the Asia Pacific fish vaccines market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Japan dominated the Asia Pacific fish vaccines market share in 2022.
Choong Ang Vaccine Laboratories Co.; Elanco Animal Health Inc; Hipra SA; INDIAN IMMUNOLOGICALS LTD; KBNP Inc.; Kyoto Biken Laboratories; Merck & Co Inc.; Nisseiken Co., Ltd.; Phibro Animal Health Corp; Vaxxinova International BV; and Zoetis Inc. are some of the leading companies operating in the Asia Pacific fish vaccines market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Asia Pacific fish vaccines market was valued at US$ 46.87 million in 2022 and is expected to reach US$ 94.15 million by 2030, registering a CAGR of 9.1% from 2022 to 2030. Surging demand for aquatic animal-derived food products is among the critical factors attributed to the Asia Pacific fish vaccines market expansion.
An unhealthy diet is a growing concern in developing and developed countries, resulting in a variety of negative health consequences. Thus, fish is highly advisable in diet for healthy growth and development as it is rich in vitamins, minerals, lipids, and macronutrients such as proteins. Additionally, it is believed that aquaculture is the most effective way to produce high-quality proteins for a sustainable human diet. Growing awareness regarding the nutritional benefits of fish consumption propels the demand for sustainable, high-quality, and healthy meat products. Therefore, the rising consumption of fish and fish-derived products fuels the fish vaccines market growth.
On the contrary, stringent regulations for approval of vaccine hurdles the growth of Asia Pacific fish vaccines market.
Based on vaccine type, the Asia Pacific fish vaccines market is categorized into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held 72.9% market share in 2022, amassing US$ 34.15 million. It is projected to garner US$ 69.58 million by 2030 to expand at 9.3% CAGR during 2022-2030.
Based on application, the Asia Pacific fish vaccines market is categorized into bacterial infection, viral infection, and parasitic. The bacterial infection segment held 81.5% share of Asia Pacific fish vaccines market in 2022, amassing US$ 38.21 million. It is projected to garner US$ 77.58 million by 2030 to expand at 9.3% CAGR during 2022-2030.
Based on route of administration, the Asia Pacific fish vaccines market is categorized into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held 59.5% share of Asia Pacific fish vaccines market in 2022, amassing US$ 27.89 million. It is projected to garner US$ 55.71 million by 2030 to expand at 9.0% CAGR during 2022-2030.
Based on species, the Asia Pacific fish vaccines market is categorized into salmon, trout, tilapia, and others. The salmon segment held 71.2% share of Asia Pacific fish vaccines market in 2022, amassing US$ 33.37 million. It is projected to garner US$ 66.36 million by 2030 to expand at 9.0% CAGR during 2022-2030.
Based on country, the Asia Pacific fish vaccines market has been categorized China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that Japan captured 28.9% share of Asia Pacific fish vaccines market in 2022. It was assessed at US$ 13.54 million in 2022 and is likely to hit US$ 28.10 million by 2030, exhibiting a CAGR of 9.6% during 2022-2030.
Key players operating in the Asia Pacific fish vaccines market are Choong Ang Vaccine Laboratories Co.; Elanco Animal Health Inc; Hipra SA; INDIAN IMMUNOLOGICALS LTD; KBNP Inc.; Kyoto Biken Laboratories; Merck & Co Inc.; Nisseiken Co., Ltd.; Phibro Animal Health Corp; Vaxxinova International BV; and Zoetis Inc., among others.
– In Nov 2020, IIL partners with CIFE to develop the first fish vaccine.
– In July 2020, Zoetis Acquires Fish Vet Group to Enhance Aquaculture Diagnostic Capabilities.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific fish vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific fish vaccines market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Asia Pacific Fish Vaccine Market
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Fish Vaccine Market – Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Government Initiatives to Develop Aquaculture Industry
4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
4.2 Market Restraints
4.2.1 Stringent Regulations for Approval of Vaccine
4.3 Market Opportunities
4.3.1 Development of Novel Fish Vaccine
4.4 Future Trends
4.4.1 Technological Advancements in Fish Vaccine
4.5 Impact Analysis:
5. Fish Vaccine Market – Asia Pacific Market Analysis
5.1 Fish Vaccine Market Revenue (US$ Th), 2022 – 2030
6. Asia Pacific Fish Vaccine Market – Revenue and Forecast to 2030 – by Vaccine Type
6.1 Overview
6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
6.3 Inactivated Vaccines
6.3.1 Overview
6.3.2 Inactivated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.4 Live Attenuated Vaccines
6.4.1 Overview
6.4.2 Live Attenuated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.5 Subunit Vaccines
6.5.1 Overview
6.5.2 Subunit Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.6 Recombinant Vector Vaccine
6.6.1 Overview
6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.7 Others
6.7.1 Overview
6.7.2 Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7. Asia Pacific Fish Vaccine Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
7.3 Bacterial Infection
7.3.1 Overview
7.3.2 Bacterial Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.4 Viral Infection
7.4.1 Overview
7.4.2 Viral Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.5 Parasitic
7.5.1 Overview
7.5.2 Parasitic: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8. Asia Pacific Fish Vaccine Market – Revenue and Forecast to 2030 – by Route of Administration
8.1 Overview
8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
8.3 Injection vaccine
8.3.1 Overview
8.3.2 Injection vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8.4 Immersion Vaccine
8.4.1 Overview
8.4.2 Immersion Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8.5 Oral Vaccine
8.5.1 Overview
8.5.2 Oral Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9. Asia Pacific Fish Vaccine Market – Revenue and Forecast to 2030 – by Species
9.1 Overview
9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
9.3 Salmon
9.3.1 Overview
9.3.2 Salmon: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.4 Trout
9.4.1 Overview
9.4.2 Trout: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.5 Tilapia
9.5.1 Overview
9.5.2 Tilapia: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.6 Others
9.6.1 Overview
9.6.2 Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
10. Asia Pacific Fish Vaccine Market – Country Analysis
10.1 Asia Pacific Fish Vaccine Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 Asia Pacific Fish Vaccine Market, by Country
10.1.2.1 China
10.1.2.1.1 Overview
10.1.2.1.2 China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.1.3 China: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.1.4 China: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.1.5 China: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.1.6 China: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.2 Japan
10.1.2.2.1 Overview
10.1.2.2.2 Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.2.3 Japan: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.2.4 Japan: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.2.5 Japan: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.2.6 Japan: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.3 India
10.1.2.3.1 Overview
10.1.2.3.2 India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.3.3 India: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.3.4 India: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.3.5 India: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.3.6 India: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.4 Australia
10.1.2.4.1 Overview
10.1.2.4.2 Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.4.3 Australia: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.4.4 Australia: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.4.5 Australia: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.4.6 Australia: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.5 South Korea
10.1.2.5.1 Overview
10.1.2.5.2 South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.5.3 South Korea: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.5.4 South Korea: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.5.5 South Korea: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.5.6 South Korea: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.6 Rest of Asia Pacific
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.6.3 Rest of Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.6.4 Rest of Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.6.5 Rest of Asia Pacific: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.6.6 Rest of Asia Pacific: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
11. Fish Vaccine Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in Fish Vaccine Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Zoetis Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merck & Co Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 HIPRA SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Phibro Animal Health Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Vaxxinova International BV
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Kyoto Biken Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Elanco Animal Health Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Nisseiken Co Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 KBNP Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Choong Ang Vaccine Laboratory
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Indian Immunologicals Ltd
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Fish Vaccine Market Segmentation
Table 2. Worldwide Fish Production and Consumption in 2022
Table 3. Major Bacterial Diseases in Fish
Table 4. Major Viral Diseases in Fish
Table 5. Major Parasitic Diseases in Fish
Table 6. Atlantic Salmon Production 2020
Table 7. China Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 8. China Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 9. China Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 10. China Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 11. Japan Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 12. Japan Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 13. Japan Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 14. Japan Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 15. India Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 16. India Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 17. India Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 18. India Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 19. Australia Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 20. Australia Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 21. Australia Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 22. Australia Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 23. South Korea Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 24. South Korea Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 25. South Korea Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 26. South Korea Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 27. Rest of Asia Pacific Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 28. Rest of Asia Pacific Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 29. Rest of Asia Pacific Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 30. Rest of Asia Pacific Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 31. Recent Inorganic Growth Strategies in the Fish Vaccine Market
Table 32. Recent Organic Growth Strategies in Fish Vaccine Market
Table 33. Glossary of Terms, Asia Pacific Fish Vaccine Market
LIST OF FIGURES
Figure 1. Asia Pacific Fish Vaccine Market Segmentation, By Country
Figure 2. Asia Pacific Fish Vaccine Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Fish Vaccine Market Revenue (US$ Th), 2022 – 2030
Figure 5. Asia Pacific Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
Figure 6. Inactivated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 7. Live Attenuated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 8. Subunit Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 10. Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 11. Asia Pacific Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 12. Bacterial Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 13. Viral Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 14. Parasitic: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 15. Asia Pacific Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
Figure 16. Injected: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 17. Immersion Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 18. Oral Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
Figure 20. Salmon: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 21. Trout: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 22. Tilapia: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 23. Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 24. Asia Pacific Fish Vaccine Market, by Key Country – Revenue, 2022 (US$ Thousand)
Figure 25. Asia Pacific Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
Figure 26. China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 27. Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 28. India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 29. Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 30. South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 31. Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 32. Growth Strategies in Fish Vaccine Market
The List of Companies – Asia Pacific Fish Vaccines Market
1. Choong Ang Vaccine Laboratories Co.
2. Elanco Animal Health Inc
3. Hipra SA
4. INDIAN IMMUNOLOGICALS LTD
5. KBNP Inc.
6. Kyoto Biken Laboratories
7. Merck & Co Inc.
8. Nisseiken Co., Ltd.
9. Phibro Animal Health Corp
10. Vaxxinova International BV
11. Zoetis Inc.
You must be logged in to post a review.
Reviews
There are no reviews yet.